References
- Tam W, Roberts-Thomson I. Gastrointestinal: Atrophic gastritis and antral intestinal metaplasia. J Gastroenterol Hepatol. 2002;17(11):1227.
- Glass GB, Pitchumoni CS. Atrophic gastritis. Hum Pathol. 1975;6(2):219-50.
- El-Zimaity HM. Recent advances in the histopathology of gastritis. Curr Diagn Pathol. 2007;13(4):340-8.
- Israel DA, Peek RM. Mechanisms of Helicobacter pylori-Induced Gastric Inflammation. In: Said HM, editor. Physiology of the Gastrointestinal Tract. 6th ed. Academic Press; 2018. p. 1517-45.
- Sipponen P, Hyvärinen H. Role of Helicobacter pylori in the pathogenesis of gastritis, peptic ulcer and gastric cancer. Scand J Gastroenterol Suppl. 1993;196:3-6.
- Suzuki H, Ishii H. Role of apoptosis in Helicobacter pylori-associated gastric mucosal injury. J Gastroenterol Hepatol. 2000;15:46-54.
- Rodriguez-Castro KI, Franceschi M, Noto A, et al. Clinical manifestations of chronic atrophic gastritis. Acta Biomed. 2018;89(8-S):88-92.
- Dimitrova Kovacheva-Slavova M, Asenov Angelov T, Yankov Valkov H, Ilianov Iliev H, Georgiev Vladimirov B. Current View on Autoimmune Gastritis. In: Chai J, editor. Gastritis - New Approaches and Treatments. IntechOpen; 2019.
- Toh BH, Alderuccio F. Pernicious Anaemia. Autoimmunity. 2004;37(4):357-61.
- Lenti MV, Rugge M, Lahner E, et al. Autoimmune gastritis. Nat Rev Dis Primers. 2020;6(1):56.
- Neumann WL, Coss E, Rugge M, Genta RM. Autoimmune atrophic gastritis--pathogenesis, pathology and management. Nat Rev Gastroenterol Hepatol. 2013;10(9):529-41.
- Coati I, Fassan M, Farinati F, Graham DY, Genta RM, Rugge M. Autoimmune gastritis: Pathologist’s viewpoint. World J Gastroenterol. 2015;21(42):12179-89.
- Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. Am J Surg Pathol. 1996;20(10):1161-81.
- Correa P, Piazuelo MB. The gastric precancerous cascade. J Dig Dis. 2012;13(1):2-9.
- Fraser A, Delaney BC, Ford AC, Qume M, Moayyedi P. The Short-Form Leeds Dyspepsia Questionnaire validation study. Aliment Pharmacol Ther. 2007;25(4):477-86.
- Misiewicz JJ. The Sydney System: a new classification of gastritis. Introduction. J Gastroenterol Hepatol. 1991;6(3):207-8.
- El-Zimaity HM, Graham DY. Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System. Hum Pathol. 1999;30(1):72-7.
- Rotimi O, Cairns A, Gray S, Moayyedi P, Dixon MF. Histological identification of Helicobacter pylori: comparison of staining methods. J Clin Pathol. 2000;53(10):756-9.
- Ohtani M, García A, Rogers AB, et al. Protective role of 17β-estradiol against the development of Helicobacter pylori-induced gastric cancer in INS-GAS mice. Carcinogenesis. 2011;32(8):1244-50.
- Nishizawa T, Suzuki H, Sakitani K, et al. Family history is an independent risk factor for the progression of gastric atrophy among patients with Helicobacter pylori infection. United European Gastroenterol J. 2018;6(5):781-8.
- Niv Y. Helicobacter pylori and gastric mucin expression: A systematic review and meta-analysis. World J Gastroenterol. 2015;21(31):9430-6.
- Zagari RM, Rabitti S, Greenwood DC, Eusebi LH, Vestito A, Bazzoli F. Systematic review with meta-analysis: diagnostic performance of the combination of pepsinogen, gastrin-17 and anti-Helicobacter pylori antibodies serum assays for the diagnosis of atrophic gastritis. Aliment Pharmacol Ther. 2017;46(7):657-67.
- Lahner E, Annibale B. Pernicious anemia: new insights from a gastroenterological point of view. World J Gastroenterol. 2009;15(41):5121-8.
- Tack J, Piessevaux H, Coulie B, Caenepeel P, Janssens J. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology. 1998;115(6):1346-52.
- Minalyan A, Benhammou JN, Artashesyan A, Lewis MS, Pisegna JR. Autoimmune atrophic gastritis: current perspectives. Clin Exp Gastroenterol. 2017;10:19-27.
- Suzuki H, Nishizawa T, Hibi T. Helicobacter pylori eradication therapy. Future Microbiol. 2010;5(4):639-48.
- Franceschi F, Gasbarrini A, Polyzos SA, Kountouras J. Extragastric diseases and Helicobacter pylori. Helicobacter. 2015;20 Suppl 1:40-6.
- Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988;48(13):3554-60.
- Vannella L, Lahner E, Osborn J, Annibale B. Systematic review: gastric cancer incidence in pernicious anaemia. Aliment Pharmacol Ther. 2013;37(4):375-82.
- Rugge M, Pennelli G, Pilozzi E, et al. Gastritis: the histology report. Dig Liver Dis. 2011;43 Suppl 4:S373-84.
- Hershko C, Ronson A, Souroujon M, Maschler I, Heyd J, Patz J. Variable hematologic presentation of autoimmune gastritis: age-related progression from iron deficiency to cobalamin depletion. Blood. 2006;107(4):1673-9.
- Leung WK, Lin SR, Ching JY, et al. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut. 2004;53(9):1244-9.
- Dockray GJ. Clinical endocrinology and metabolism. Gastrin. Best Pract Res Clin Endocrinol Metab. 2004;18(4):555-68.
- Pormohammad A, Nasiri MJ, Ghorbani S, et al. Association of Helicobacter pylori with gastric cancer and its risk factors: A meta-analysis. J Cell Physiol. 2019;234(6):8874-83.
- Kokkola A, Sjöblom SM, Haapiainen R, Sipponen P, Puolakkainen P, Järvinen H. The risk of gastric carcinoma and carcinoid tumours in patients with pernicious anaemia. A prospective follow-up study. Scand J Gastroenterol. 1998;33(1):88-92.
- Vannella L, Lahner E, Annibale B. Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisal. World J Gastroenterol. 2012;18(12):1279-85.
- Wroblewski LE, Peek RM Jr, Wilson KT. Helicobacter pylori and gastric cancer: factors that modulate disease risk. Clin Microbiol Rev. 2010;23(4):713-39.
- Blaser MJ. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis. 1999;179(6):1523-1530. doi:10.1086/314785.
- Wang L, Cao ZM, Zhang LL, et al. Helicobacter Pylori and Autoimmune Diseases: Involving Multiple Systems. Front Immunol. 2022;13:833424.
- Weck MN, Brenner H. Association of Helicobacter pylori infection with chronic atrophic gastritis: Meta-analyses according to type of disease definition. Int J Cancer. 2008;123(4):874-81.
- Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol. 2017;112(2):212-39.
- Muhsen K, Nir A, Spungin-Bialik A, Bassal R, Goren S, Cohen D. Interaction among ethnicity, socioeconomic status, and Helicobacter pylori seroprevalence in Israeli children and adolescents. J Pediatr Gastroenterol Nutr. 2011;53(5):524-7.
- Kulnigg-Dabsch S, Schmid W, Howaldt S, et al. Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial. Inflamm Bowel Dis. 2013;19(8):1609-16.
- Massironi S, Zilli A, Elvevi A, Invernizzi P. The changing face of chronic autoimmune atrophic gastritis: an updated comprehensive perspective. Autoimmun Rev. 2019;18(3):215-22.
- Lee YC, Chiang TH, Chou CK, et al. Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis. Gastroenterology. 2016;150(5):1113-24.e5.
- Brown KL, Wray AE, Wood CL, et al. A systematic review of the gastrointestinal manifestations of Fabry disease. J Inherit Metab Dis. 2019;42(1):29-39.